Fund Universe

Tetragon Partners GP Ltd

CIK 0001515070 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.727
AUM ($M)
614
Positions
32
Turnover
0.12
Top-10 wt
77%
Herfindahl
0.309
History (qtrs)
6
Excess Return
+61.1%

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 39 positions · portfolio value $614M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
PATH funds › UIPATH INC ADD 54.8% -0.2% 336.4 30,950,000 +5,742,372 5
KGEI funds › KOLIBRI GLOBAL ENERGY INC HOLD 5.5% -1.9% 33.8 6,834,504 +0 5
AUTL funds › AUTOLUS THERAPEUTICS LTD HOLD 2.5% -0.1% 15.2 9,500,000 +0 5
LYFT funds › LYFT INC HOLD 2.4% -0.2% 14.6 1,000,000 +0 5
DFTX funds › DEFINIUM THERAPEUTICS INC ADD 2.2% +1.5% 13.5 286,990 +86,996 2 +536.1%
WK funds › WORKIVA INC HOLD 2.0% -1.0% 12.1 250,000 +0 5 -26.4%
CXM funds › SPRINKLR INC HOLD 1.8% -0.7% 11.4 2,200,000 +0 5
MBX funds › MBX BIOSCIENCES INC ADD 1.8% +1.0% 11.2 203,543 +58,063 4 +346.4%
ALKT funds › ALKAMI TECHNOLOGY INC NEW 1.8% +1.8% 10.9 600,284 +600,284 1 +101.4%
CLDX funds › CELLDEX THERAPEUTICS INC NEW TRIM 1.8% -0.2% 10.8 290,441 -21,875 5
RLAY funds › RELAY THERAPEUTICS INC ADD 1.7% +1.4% 10.7 570,311 +388,768 2 +357.8% re-entry
ARWR funds › ARROWHEAD PHARMACEUTICALS IN ADD 1.7% +0.2% 10.6 130,484 +3,286 4 +302.4%
PHVS funds › PHARVARIS N V ADD 1.7% +0.4% 10.2 295,627 +74,016 5
ALKS funds › ALKERMES PLC ADD 1.6% +0.5% 10.0 189,979 +30,188 5 +17.7%
IMVT funds › IMMUNOVANT INC ADD 1.6% +0.5% 9.9 255,934 +37,427 5
SLN funds › SILENCE THERAPEUTICS PLC ADD 1.4% +0.7% 8.4 764,256 +134,095 3 +139.2%
DYN funds › DYNE THERAPEUTICS INC ADD 1.3% +0.4% 7.9 356,657 +98,525 5 +61.1%
IONS funds › IONIS PHARMACEUTICALS INC ADD 1.3% +0.6% 7.7 97,173 +55,409 2 -82.9%
AGIO funds › AGIOS PHARMACEUTICALS INC ADD 1.2% +0.1% 7.6 205,579 +40,740 3 -57.5%
HRMY funds › HARMONY BIOSCIENCES HLDGS IN ADD 1.2% +0.5% 7.3 201,036 +81,696 3 -7.7%
KRYS funds › KRYSTAL BIOTECH INC HOLD 1.2% +0.2% 7.3 19,668 +0 4 +99.6%
ANNX funds › ANNEXON INC TRIM 1.2% -0.3% 7.1 1,242,455 -50,000 5
CELC funds › CELCUITY INC NEW 1.1% +1.1% 6.7 64,110 +64,110 1 -102.0%
WBD funds › WARNER BROS DISCOVERY INC TRIM 1.1% -3.9% 6.7 250,000 -673,725 2 -36.9%
NKTR funds › NEKTAR THERAPEUTICS TRIM 1.0% -0.5% 6.1 86,996 -16,041 3 +7.2%
AMLX funds › AMYLYX PHARMACEUTICALS INC TRIM 0.9% +0.0% 5.4 297,926 -19,951 5 +207.3%
ACAD funds › ACADIA PHARMACEUTICALS INC ADD 0.7% +0.1% 4.2 167,875 +23,255 2 +21.5% re-entry
CUE funds › CUE BIOPHARMA INC NEW 0.5% +0.5% 3.0 93,819 +93,819 1 +578.5%
SNOW funds › SNOWFLAKE INC HOLD 0.4% +0.1% 2.5 10,000 +0 5
ACRS funds › ACLARIS THERAPEUTICS INC NEW 0.3% +0.3% 2.1 400,000 +400,000 1 +186.0%
TECX funds › TECTONIC THERAPEUTIC INC ADD 0.3% +0.0% 1.6 46,516 +8,928 2 +149.7% re-entry
GLUE funds › MONTE ROSA THERAPEUTICS INC NEW 0.2% +0.2% 1.4 56,052 +56,052 1 -70.6%
KPTI funds › KARYOPHARM THERAPEUTICS INC EXIT 0.0% -0.1% 0.0 0 -52,984 0 -106.3%
CUSIP:834203309 funds › SOLENO THERAPEUTICS INC EXIT 0.0% -0.7% 0.0 0 -102,125 0
AXSM funds › AXSOME THERAPEUTICS INC. EXIT 0.0% -0.7% 0.0 0 -20,059 0
RARE funds › ULTRAGENYX PHARMACEUTICAL IN EXIT 0.0% -0.2% 0.0 0 -39,473 0 +69.6% re-entry
AARD funds › AARDVARK THERAPEUTICS INC EXIT 0.0% -0.2% 0.0 0 -316,621 0 -137.7%
MPLT funds › MAPLIGHT THERAPEUTICS INC EXIT 0.0% -0.4% 0.0 0 -112,115 0 +251.8%
PRAX funds › PRAXIS PRECISION MEDICINES I EXIT 0.0% -1.0% 0.0 0 -15,952 0 +139.4%

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 614 32 0.12 77% 0.309 0.726 in
2026Q1 509 34 0.14 83% 0.315 0.742 in
2025Q4 474 28 0.45 87% 0.374 0.156 in
2025Q3 689 43 0.15 84% 0.183 0.730 in
2025Q2 554 36 0.34 84% 0.169 0.361 entered
2025Q1 312 30 0.00 85% 0.143 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status